Kilitch Drugs (India)
KILITCHNSE

Kilitch Drugs (India)

₹310.60-17.15 (5.23%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
306.60
Today’s high
327.70
52 week low
293.53
52 week high
500.00
Open price
327.70
Previous close
327.75
Live volume
16,487
Lower circuit
248.50
Upper circuit
372.70

Fundamentals

Market Cap
₹546Cr
ROE
10.38%
P/E Ratio(TTM)
21.96
EPS(TTM)
14.21
P/B Ratio
2.05
Dividend Yield
0.00%
Industry P/E
32.86
Book Value
151.97
Debt to Equity
0.31
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Kilitch Drugs (India) Limited is one of the world's leading and fastest-growing pharmaceutical companies, manufacturing and supplying a broad range of formulations globally. The company embraces purpose-driven leadership to create long-term value beyond financial performance, establishing itself as a significant entity in the pharmaceutical industry. It is committed to achieving sustainable healthcare by optimizing its processes and practices through continuous innovation and sustainable operations. Its extensive research has developed a diverse portfolio targeting chronic and acute treatments, including injectables, ophthalmics, effervescent tablets, and nutraceuticals. With a formidable presence across Asia, Africa, CIS, and Latin America, the company offers a broad product portfolio to suit each country's needs. A key international asset is its Ethiopia Unit, the largest Cephalosporin plant in East Africa, producing tablets, capsules, and injectables.;
MD/CEO
Mukund Mehta
Founded in
1992
NSE symbol
KILITCH

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
63.77%
Retail And Others
36.23%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹4,390.00
-56.00 (1.26%)
L
    H
    1,48,509.8665.3717.58
    Ajanta PharmaAJANTPHARM
    ₹3,030.60
    -88.90 (2.85%)
    L
      H
      37,841.7537.38.77
      ₹1,626.60
      -28.70 (1.73%)
      L
        H
        26,818.2331.662.8
        ₹1,321.10
        -30.50 (2.26%)
        L
          H
          18,266.8838.85.2
          2026
          11
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Result
          Release date
          13
          Aug
          Quarterly Result
          Release date

          15
          Jul
          Rights Entitlement
          Ex date
          2:23
          Ratio

          2 rights eligible for every 23 existing shares held
          Ratio2:23
          Offer price₹357.00
          Ex date15 Jul ‘25
          Record date15 Jul ‘25
          Announcement date9 Jul ‘25

          9
          Jul
          Rights Entitlement
          Announced
          2:23
          Ratio

          2 rights eligible for every 23 existing shares held
          Ratio2:23
          Offer price₹357.00
          Ex date15 Jul ‘25
          Record date15 Jul ‘25
          Announcement date9 Jul ‘25
          19
          May
          Quarterly & Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2024
          12
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          27
          May
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks